Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Werewolf Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −2 vs. Q1 2022
- Shares held
- 19.1M
- +56.4K (+0.3%) vs. Q1 2022
- Total value
- $78.0M
- −$5.50M (−6.6%) vs. Q1 2022
- New holders
- 14
- 7 more added
- Sold out
- 16
- 15 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.2M |
| Q1 2024 | 61 | $209.0M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $83.5M |
| Q4 2021 | 51 | $228.3M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 50 | $0 | 0.00% | −5,697−99.1% | Reduced |
| Barclays PLC | 108 | $0 | 0.00% | −4,179−97.5% | Reduced |
| Daiwa Securities Group Inc. | 80 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 14 | $0 | 0.00% | +14 | New |
| Group One Trading, L.P. | 15 | $0 | 0.00% | +15 | New |
| Glassman Wealth Services | 5 | $0 | 0.00% | +5 | New |
| Ellevest, Inc. | 31 | $0 | 0.00% | +31 | New |
| New York State Common Retirement Fund | 187 | $1.00K | 0.00% | −13,866−98.7% | Reduced |
| Royal Bank of Canada | 233 | $1.00K | 0.00% | −1,389−85.6% | Reduced |
| Financial Perspectives, Inc | 250 | $1.02K | 0.00% | 00.0% | Unchanged |
| Oliver Lagore Vanvalin Investment Group | 580 | $2.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 736 | $3.00K | 0.00% | −1,946−72.6% | Reduced |
| Tower Research Capital LLC (TRC) | 2,343 | $10.0K | 0.00% | −374−13.8% | Reduced |
| Bank of America Corp | 2,694 | $11.0K | 0.00% | −19,623−87.9% | Reduced |
| JPMorgan Chase & Co | 3,698 | $15.0K | 0.00% | −11,929−76.3% | Reduced |
| UBS Group AG | 4,257 | $18.0K | 0.00% | +2,154+102.4% | Added |
| Goldman Sachs Group Inc | 10,983 | $45.0K | 0.00% | −672−5.8% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 11,124 | $45.0K | 0.01% | +11,124 | New |
| Cubist Systematic Strategies, LLC | 13,250 | $54.0K | 0.00% | +13,250 | New |
| Northern Trust Corp | 13,818 | $57.0K | 0.00% | −181,250−92.9% | Reduced |
| Renaissance Technologies LLC | 16,800 | $69.0K | 0.00% | +16,800 | New |
| Bailard, Inc. | 21,200 | $87.0K | 0.00% | +21,200 | New |
| Morgan Stanley | 22,286 | $91.0K | 0.00% | +14,656+192.1% | Added |
| Qube Research & Technologies Ltd | 22,535 | $92.0K | 0.00% | +22,535 | New |
| State Street Corp | 24,568 | $100.0K | 0.00% | −310,519−92.7% | Reduced |
| Bridgeway Capital Management, LLC | 36,211 | $148.0K | 0.00% | +36,211 | New |
| Caas Capital Management LP | 62,599 | $256.0K | 0.03% | −38,996−38.4% | Reduced |
| Geode Capital Management, LLC | 79,280 | $324.0K | 0.00% | −209,025−72.5% | Reduced |
| Ergoteles LLC | 129,000 | $528.0K | 0.02% | +129,000 | New |
| BlackRock Inc. | 183,957 | $752.0K | 0.00% | −1,099,588−85.7% | Reduced |
| Rubric Capital Management LP | 204,996 | $838.0K | 0.04% | +204,996 | New |
| Alyeska Investment Group, L.P. | 206,201 | $843.0K | 0.01% | 00.0% | Unchanged |
| Platinum Investment Management Ltd | 213,381 | $873.0K | 0.03% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 246,305 | $1.01M | 0.18% | +246,305 | New |
| Millennium Management LLC | 248,917 | $1.02M | 0.00% | +206,516+487.1% | Added |
| Vanguard Group Inc | 396,069 | $1.62M | 0.00% | −126,018−24.1% | Reduced |
| FMR LLC | 518,772 | $2.12M | 0.00% | +1370.0% | Added |
| Laurion Capital Management LP | 535,160 | $2.19M | 0.09% | +535,160 | New |
| DC Funds, LP | 589,102 | $2.41M | 33.24% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 597,003 | $2.44M | 0.46% | +12,800+2.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 958,125 | $3.92M | 0.08% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,000,597 | $4.09M | 0.01% | +25,000+2.6% | Added |
| PFM Health Sciences, LP | 1,730,723 | $7.08M | 0.28% | +1,145,396+195.7% | Added |
| MPM Oncology Impact Management LP | 2,388,011 | $9.77M | 2.71% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,284,172 | $17.5M | 7.39% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,291,881 | $17.6M | 0.47% | 00.0% | Unchanged |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −187,500−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −68,338−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −60,646−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Evercore Wealth Management, LLC | 0 | $0 | 0.00% | −46,500−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −22,550−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −20,144−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −15,180−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −14,349−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −13,111−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −11,286−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −3,946−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −2,613−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,041−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −36,879−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |